NICM
CORT icon

Neo Ivy Capital Management’s Corcept Therapeutics CORT Stock Holding History

Neo Ivy Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,505
Closed -$947K – 388
2026
Q1 		$947K Sell
23,505
-328
-1% -$12.3K 0.25% 143
2025
Q4 		$829K Buy
+23,833
New +$1.87M 0.13% 182
2025
Q3 		– Sell
-1,419
Closed -$104K – 411
2025
Q2 		$104K Sell
1,419
-5,553
-80% -$403K 0.03% 292
2025
Q1 		$796K Buy
+6,972
New +$424K 0.25% 130
2023
Q4 		– Sell
-2,424
Closed -$66K – 318
2023
Q3 		$66K Sell
2,424
-2,178
-47% -$63K 0.03% 270
2023
Q2 		$102K Buy
+4,602
New +$106K 0.05% 237
2022
Q4 		$453K Buy
22,314
+22,255
+37,720% +$558K 0.31% 166
2022
Q3 		$2K Buy
+59
New +$1.58K 0.01% 357
2022
Q2 		– Sell
-4,980
Closed -$112K – 439
2022
Q1 		$112K Buy
+4,980
New +$106K 0.1% 289
2021
Q3 		– Sell
-1,529
Closed -$34K – 494
2021
Q2 		$34K Sell
1,529
-11,890
-89% -$265K 0.03% 346
2021
Q1 		$319K Buy
+13,419
New +$358K 0.35% 99
2020
Q4 		– Sell
-510
Closed -$8K – 441
2020
Q3 		$8K Buy
+510
New +$8.13K 0.01% 431

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neo Ivy Capital Management's CORT Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 23,505 shares — an estimated $947K sold.

Neo Ivy Capital Management first reported a position in CORT in Q3 2020 and held it in 12 quarters. The position peaked at $947K in Q1 2026. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 23,505 Corcept Therapeutics shares in Q2 2026, an estimated $947K.
  • Neo Ivy Capital Management first reported a position in Corcept Therapeutics in Q3 2020 and held it in 12 quarters.
  • Neo Ivy Capital Management's Corcept Therapeutics position peaked at $947K in Q1 2026.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.